Literature DB >> 15128616

Vestibular-evoked muscle responses in patients with spinal cord injury.

J F Iles1, Alima S Ali, Gordana Savic.   

Abstract

The vestibular system was activated by galvanic electrical stimulation in 22 patients with spinal cord injury. Three patients were studied standing and all were studied sitting. Electromyographic responses recorded in soleus (standing patients) and the erectores spinae (all patients) were compared with data from 18 control subjects. The vestibular stimulus polarity and head position were arranged so as to produce excitatory medium latency muscle responses in the controls. Responses in the patient group were present bilaterally, present unilaterally or absent below the level of injury. The amplitude of response recorded in erectores spinae at lumbar levels below the lesion in 21 patients (left and right side responses summed) and five control subjects was positively correlated with American Spinal Injuries Association (ASIA) grade: the smallest amplitudes were found in patients with the most severe impairment (Spearman rank correlation coefficient rs = 0.59; P = 0.002, two-tailed). The latency of response (averaged for both sides) was negatively correlated with ASIA grade in 21 patients: the longest latencies were found in patients with the most severe impairment (rs = -0.57; P < 0.01, two-tailed). Amplitude and latency were negatively correlated (rs = -0.72, P < 0.002, two-tailed). The latencies of responses recorded in the erectores spinae at different vertebral levels were linearly related to the vertical distance from the inion to the recording site in both patient and control groups. The conduction velocities of the spinal pathways activated by vestibular stimulation were 4.6 and 10.4 m/s in patient (recording below lesion) and control groups, respectively. Both clinical status (patients recording below lesion, patients recording above lesion and controls) and distance were significant predictors of latency (general linear model, P < 0.0005). It is concluded that measurement of vestibular-evoked responses could provide information on the level and density of spinal cord lesions. Copyright 2004 Guarantors of Brain

Entities:  

Mesh:

Year:  2004        PMID: 15128616     DOI: 10.1093/brain/awh173

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

1.  Use of galvanic vestibular feedback to control postural orientation in decerebrate rabbits.

Authors:  P V Zelenin; L-J Hsu; G N Orlovsky; T G Deliagina
Journal:  J Neurophysiol       Date:  2012-03-07       Impact factor: 2.714

2.  Human standing and walking: comparison of the effects of stimulation of the vestibular system.

Authors:  John F Iles; Richard Baderin; Rachel Tanner; Ariel Simon
Journal:  Exp Brain Res       Date:  2006-10-10       Impact factor: 1.972

3.  Impaired scaling of responses to vestibular stimulation in incomplete SCI.

Authors:  S Wydenkeller; M Liechti; R Müller; A Curt
Journal:  Exp Brain Res       Date:  2006-09-28       Impact factor: 1.972

4.  Contribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Luciana Cristina Matos Cunha; Maurício Campelo Tavares; Carlos Julio Tierra Criollo; Ludimila Labanca; Clarissa Cardoso Dos Santos Couto Paz; Henrique Resende Martins; Anna Bárbara de Freitas Carneiro-Proietti; Denise Utsch Goncalves
Journal:  J Clin Neurol       Date:  2013-10-31       Impact factor: 3.077

5.  Electrical vestibular stimuli to enhance vestibulo-motor output and improve subject comfort.

Authors:  Patrick A Forbes; Christopher J Dakin; Anoek M Geers; Martijn P Vlaar; Riender Happee; Gunter P Siegmund; Alfred C Schouten; Jean-Sébastien Blouin
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

6.  Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing.

Authors:  Júlia Fonseca de Morais Caporali; Ludimila Labanca; Kyonis Rodrigues Florentino; Bárbara Oliveira Souza; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

7.  Multimodal cortical and subcortical exercise compared with treadmill training for spinal cord injury.

Authors:  Stephanie A Martinez; Nhuquynh D Nguyen; Eric Bailey; Denis Doyle-Green; Henry A Hauser; John P Handrakis; Steven Knezevic; Casey Marett; Jennifer Weinman; Angelica F Romero; Tiffany M Santiago; Ajax H Yang; Lok Yung; Pierre K Asselin; Joseph P Weir; Stephen D Kornfeld; William A Bauman; Ann M Spungen; Noam Y Harel
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

8.  Electrophysiological analysis shows dizziness as the first symptom in human T cell lymphotropic virus type-associated myelopathy/tropical spastic paraparesis.

Authors:  Ludimila Labanca; Ana Lúcia Borges Starling; Silvio Roberto de Sousa-Pereira; Luiz Cláudio Ferreira Romanelli; Anna Bárbara de Freitas Carneiro-Proietti; Lucas Novaes Carvalho; Daniele Rosa Fernandes; Denise Utsch Gonçalves
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-16       Impact factor: 2.205

9.  Vestibular Evoked Myogenic Potential (VEMP) Triggered by Galvanic Vestibular Stimulation (GVS): A Promising Tool to Assess Spinal Cord Function in Schistosomal Myeloradiculopathy.

Authors:  Júlia Fonseca de Morais Caporali; Denise Utsch Gonçalves; Ludimila Labanca; Leonardo Dornas de Oliveira; Guilherme Vaz de Melo Trindade; Thiago de Almeida Pereira; Pedro Henrique Diniz Cunha; Marina Santos Falci Mourão; José Roberto Lambertucci
Journal:  PLoS Negl Trop Dis       Date:  2016-04-29

10.  Vestibular-evoked myogenic potential triggered by galvanic vestibular stimulation may reveal subclinical alterations in human T-cell lymphotropic virus type 1-associated myelopathy.

Authors:  Ludimila Labanca; Júlia Fonseca de Morais Caporali; Sirley Alves da Silva Carvalho; José Roberto Lambertucci; Anna Bárbara de Freitas Carneiro Proietti; Luiz Cláudio Ferreira Romanelli; Paul Avan; Fabrice Giraudet; Bárbara Oliveira Souza; Kyonis Rodrigues Florentino; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.